The CytoSorb Registries
The COSMOS (CytoSorb TreatMent OF Critically Ill PatientS) Registry was opened in mid 2022 and is a company sponsored international Registry designed to provide an infrastructure for the ongoing surveillance of CytoSorb use in real-world critical care settings, and to serve as an objective, comprehensive, and scientifically-based resource to measure and improve the quality of patient selection for CytoSorb and related treatment modalities. Recruitment is ongoing.
The STAR (Safe and Timely Antithrombotic Removal) Registry was first registered with ClinicalTrials.gov in Sept 2021 and is a company sponsored multicentre European Registry designed to capture real-world clinical use patterns and associated clinical outcomes with the use of CytoSorb for the removal of antithrombotic agents. Recruitment remains ongoing.